178 related articles for article (PubMed ID: 17069979)
1. Casting light on molecular events underlying anti-cancer drug treatment: what can be seen from the proteomics point of view?
Kraljevic S; Sedic M; Scott M; Gehrig P; Schlapbach R; Pavelic K
Cancer Treat Rev; 2006 Dec; 32(8):619-29. PubMed ID: 17069979
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
Matta A; Ralhan R; DeSouza LV; Siu KW
Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
[TBL] [Abstract][Full Text] [Related]
4. The molecular make-up of a tumour: proteomics in cancer research.
Kolch W; Mischak H; Pitt AR
Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance mechanisms in cancer cells: a proteomics perspective.
Verrills NM; Kavallaris M
Curr Opin Mol Ther; 2003 Jun; 5(3):258-65. PubMed ID: 12870435
[TBL] [Abstract][Full Text] [Related]
6. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
Lee JW; Figeys D; Vasilescu J
Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
[TBL] [Abstract][Full Text] [Related]
7. Cancer proteomics: Serum diagnostics for tumor marker discovery.
Rai AJ; Chan DW
Ann N Y Acad Sci; 2004 Jun; 1022():286-94. PubMed ID: 15251974
[TBL] [Abstract][Full Text] [Related]
8. Proteomics and the haematologist.
Rees-Unwin KS; Morgan GJ; Davies FE
Clin Lab Haematol; 2004 Apr; 26(2):77-86. PubMed ID: 15053800
[TBL] [Abstract][Full Text] [Related]
9. Proteomics technology and therapeutics.
Hong ML; Jiang N; Gopinath S; Chew FT
Clin Exp Pharmacol Physiol; 2006; 33(5-6):563-8. PubMed ID: 16700895
[TBL] [Abstract][Full Text] [Related]
10. Pharmacoproteomic approach to the study of drug mode of action, toxicity, and resistance: applications in diabetes and cancer.
Chapal N; Molina L; Molina F; Laplanche M; Pau B; Petit P
Fundam Clin Pharmacol; 2004 Aug; 18(4):413-22. PubMed ID: 15312147
[TBL] [Abstract][Full Text] [Related]
11. Proteomics with two-dimensional gel electrophoresis and mass spectrometry analysis in cardiovascular research.
You SA; Wang QK
Methods Mol Med; 2006; 129():15-26. PubMed ID: 17085802
[TBL] [Abstract][Full Text] [Related]
12. Overview of molecular, cellular, and genetic neurotoxicology.
Wallace DR
Neurol Clin; 2005 May; 23(2):307-20. PubMed ID: 15757786
[TBL] [Abstract][Full Text] [Related]
13. Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs.
Chuthapisith S; Layfield R; Kerr ID; Hughes C; Eremin O
Int J Oncol; 2007 Jun; 30(6):1545-51. PubMed ID: 17487377
[TBL] [Abstract][Full Text] [Related]
14. Concise review: trends in stem cell proteomics.
Baharvand H; Fathi A; van Hoof D; Salekdeh GH
Stem Cells; 2007 Aug; 25(8):1888-903. PubMed ID: 17495109
[TBL] [Abstract][Full Text] [Related]
15. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery.
Hu S; Yen Y; Ann D; Wong DT
Drug Discov Today; 2007 Nov; 12(21-22):911-6. PubMed ID: 17993408
[TBL] [Abstract][Full Text] [Related]
16. Technologies to shape the future: proteomics applications in anesthesiology and critical care medicine.
Atkins JH; Johansson JS
Anesth Analg; 2006 Apr; 102(4):1207-16. PubMed ID: 16551925
[TBL] [Abstract][Full Text] [Related]
17. An introduction into proteomics and its clinical applications.
Ahram M
Saudi Med J; 2007 Apr; 28(4):499-507. PubMed ID: 17457467
[TBL] [Abstract][Full Text] [Related]
18. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in clinical oncoproteomics.
Jain KK
J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
[TBL] [Abstract][Full Text] [Related]
20. Protease proteomics: revealing protease in vivo functions using systems biology approaches.
Doucet A; Overall CM
Mol Aspects Med; 2008 Oct; 29(5):339-58. PubMed ID: 18571712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
